MedPath

Hannover Medical School

Hannover Medical School logo
🇩🇪Germany
Ownership
Private
Established
1965-01-01
Employees
5K
Market Cap
-
Website
http://www.mh-hannover.de

Influences of Angiotensin-neprilysin Inhibition on Sympathetic Activity in Heart Failure

Phase 2
Withdrawn
Conditions
Heart Failure
Interventions
Combination Product: sacubitril+valsartan
First Posted Date
2018-01-30
Last Posted Date
2018-10-09
Lead Sponsor
Hannover Medical School
Registration Number
NCT03415906
Locations
🇩🇪

Clinical Research Center Hannover, Hannover Medical School, Hannover, Germany

ORal IrON Supplementation With Ferric Maltol in Patients With Pulmonary Hypertension (ORION-PH-1)

Phase 3
Terminated
Conditions
Hypertension, Pulmonary
Anemia, Iron Deficiency
Interventions
Drug: Ferric maltol 30 mg (Feraccru®)
First Posted Date
2017-12-13
Last Posted Date
2020-04-21
Lead Sponsor
Hannover Medical School
Target Recruit Count
22
Registration Number
NCT03371173
Locations
🇩🇪

Hannover Medical School, Hannover, Germany

Cardiopulmonary Interactions in Patients With Heart Failure

Withdrawn
Conditions
Heart Failure
Heart Failure With Reduced Ejection Fraction
Heart Failure With Normal Ejection Fraction
Pulmonary Hypertension
First Posted Date
2017-10-23
Last Posted Date
2022-05-12
Lead Sponsor
Hannover Medical School
Registration Number
NCT03317314
Locations
🇩🇪

Hannover MS, Hannover, Lower Saxony, Germany

Exercise Training on Metabolic Syndrome Severity in Employees

Not Applicable
Completed
Conditions
Metabolic Syndrome
Interventions
Behavioral: Exercise training group
First Posted Date
2017-09-26
Last Posted Date
2023-09-21
Lead Sponsor
Hannover Medical School
Target Recruit Count
314
Registration Number
NCT03293264
Locations
🇩🇪

HannoverMS, Hannover, Lower Saxony, Germany

HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)

Phase 2
Completed
Conditions
Hepatitis E
Hepatitis Chronic Viral
Interventions
First Posted Date
2017-09-14
Last Posted Date
2019-03-08
Lead Sponsor
Hannover Medical School
Target Recruit Count
10
Registration Number
NCT03282474
Locations
🇩🇪

Charité, Campus Virchow-Klinikum, Medical Department, Division of Hepatology and Gastroenterology, Berlin, Germany

🇩🇪

University Medical Center Hamburg-Eppendorf, Center for Internal Medicine, I. Medical Clinic and Polyclinic, Hamburg, Germany

🇩🇪

Hannover Medical School, Clinic for Gastroenterology, Hepatology, and Endocrinology, Hanover, Lower Saxony, Germany

CANNAbinoids in the Treatment of TICS (CANNA-TICS)

Phase 3
Completed
Conditions
Tourette Syndrome
Tic Disorders
Interventions
Drug: placebo
First Posted Date
2017-03-22
Last Posted Date
2020-12-10
Lead Sponsor
Hannover Medical School
Target Recruit Count
98
Registration Number
NCT03087201
Locations
🇩🇪

University of Freiburg, Psychiatry and Psychotherapy, Freiburg, Germany

🇩🇪

Uniklinik RWTH Aachen, Psychiatry and Psychotherapy, Aachen, Germany

🇩🇪

University Hospital Cologne, Psychiatry and Psychotherapy, Cologne, Germany

and more 3 locations

Plasmaexchange in Early Septic Shock

Not Applicable
Conditions
Septic Shock
Interventions
Device: Plasmaexchange
First Posted Date
2017-02-28
Last Posted Date
2019-08-08
Lead Sponsor
Hannover Medical School
Target Recruit Count
352
Registration Number
NCT03065751
Locations
🇩🇪

Hannover Medical School, Hannover, Lower Saxony, Germany

Hanover Humerus Registry

Recruiting
Conditions
Proximal Humerus Fracture
First Posted Date
2017-02-23
Last Posted Date
2017-02-23
Lead Sponsor
Hannover Medical School
Target Recruit Count
1000
Registration Number
NCT03060876
Locations
🇩🇪

Hanover medical school /trauma surgery, Hanover, Lower Saxony, Germany

MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV

Phase 4
Terminated
Conditions
Hepatitis C, Chronic
Interventions
Drug: OBV/PTV/r and DSV
Drug: Placebo to match OBV/PTV/r and DSV
First Posted Date
2016-12-28
Last Posted Date
2023-08-14
Lead Sponsor
Hannover Medical School
Target Recruit Count
5
Registration Number
NCT03003338
Locations
🇩🇪

Hannover Medical School, Hannover, Germany

Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema

Phase 4
Terminated
Conditions
Diabetes Mellitus, Type II
Interventions
First Posted Date
2016-12-07
Last Posted Date
2018-09-27
Lead Sponsor
Hannover Medical School
Target Recruit Count
6
Registration Number
NCT02985242
Locations
🇩🇪

Hannover Medical School, University Eye Hospital and CRC Core Facility Hannover, Hanover, Lower Saxony, Germany

© Copyright 2025. All Rights Reserved by MedPath